Gilead Sciences to Present at Two Upcoming Investor Conferences

- Merrill Lynch Global Pharmaceutical Conference on September 16th - - UBS Global Life Sciences Conference on September 23rd - - Webcasts Available Through Gilead Corporate Website -

FOSTER CITY, Calif.--(BUSINESS WIRE)--Sept. 10, 2008--Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the company will be webcasting its corporate presentation at two upcoming investor conferences: Merrill Lynch Global Pharmaceutical Conference in London and UBS Global Life Sciences Conference in New York. These webcasts may be accessed via the company's corporate website at www.gilead.com.

John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company at both the Merrill Lynch conference on Tuesday, September 16 at 11:20 a.m. British Summer Time (6:20 a.m. Eastern Daylight Time) and at the UBS Global Life Sciences Conference on Tuesday, September 23 at 9:30 a.m. Eastern Daylight Time.

To access the live webcasts via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to each live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

CONTACT: Gilead Sciences, Inc. Susan Hubbard, 650-522-5715 Investor Relations SOURCE: Gilead Sciences, Inc.